InspireMD Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $10.8M+54.7% YoYTTM through 30 Jun 2026
Net Income -$52.5MTTM through 30 Jun 2026
Free Cash Flow -$42.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 20.2% |
| Operating Margin | -411.4% |
| Net Margin | -484.1% |
Returns
-117.7%ROE
-90.9%ROA
Balance Sheet Health
Debt / Equity0.07x
Current Ratio5.15x
Net Debt-$38.5Mnet cash position
Cash & Equivalents$15.1M
Quality Metrics
Altman Z-Score-11.73
Piotroski F-Score2 / 9
FCF Margin-391.7%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $9M
Diluted EPS-$0.61TTMFY2025: $-0.76
Dividend
No dividend
Capital Allocation
Capex Intensity11.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| United States | $1.2M | View detailsU.S. commercialization is expanding with sequential growth of 36% compared to Q4 2025. | |
| International | $2.2M | +48.0% | View detailsContinued growth in international demand through distributors. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.